title: Successful treatment of a refractory dysbiotic intestinal pseudo-obstruction in a patient with systemic sclerosis-polymyositis overlap syndrome by intravenous immunoglobulin administration possibly related to gut flora normalisation.
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Risa
authors.initials: R
authors.lastname: Kamei
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan. yamaoka@derma.med.osaka-u.ac.jp.
authors.forename: Toshifumi
authors.initials: T
authors.lastname: Yamaoka
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Kuniko
authors.initials: K
authors.lastname: Ikinaga
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Murota
authors.affiliation: Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Kentaro
authors.initials: K
authors.lastname: Shimizu
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Ichiro
authors.initials: I
authors.lastname: Katayama
mesh_terms: D064806:Dysbiosis / Q000188:drug therapy*; D000069196:Gastrointestinal Microbiome; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007418:Intestinal Pseudo-Obstruction / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D017285:Polymyositis / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy*
chemical_list: D016756:Immunoglobulins, Intravenous